Lemmens, Robin
KU Leuven
8 papers on CoChatORCID 0000-0002-4948-5956
Most cited papers
- Verified
Demographic and Geographic Vascular Risk Factor Differences in European Young Adults With Ischemic Stroke: The 15 Cities Young Stroke Study
Putaala, J., Yesilot, N., Waje-Andreassen, U., Pitkäniemi, J., Vassilopoulou, S., Nardi, K., Odier, C., Hofgart, G., Engelter, S., Burow, A., et al. (2012) · Stroke
Acute Ischemic Stroke ManagementCardiovascular Health and Risk Factors
Cited by 168
- Verified
Prediction of Outcome in Patients With Acute Ischemic Stroke Based on Initial Severity and Improvement in the First 24 h
Wouters, A., Nysten, C., Thijs, V., & Lemmens, R. (2018) · Frontiers in Neurology
Acute Ischemic Stroke ManagementStroke Rehabilitation and Recovery
Cited by 162
- Verified
In vivo synaptic density loss is related to tau deposition in amnestic mild cognitive impairment
Vanhaute, H., Ceccarini, J., Michiels, L., Koole, M., Sunaert, S., Lemmens, R., Triau, E., Emsell, L., Vandenbulcke, M., & Van Laere, K. (2020) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 88
- Verified
The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology
Lemmens, R., Buysschaert, I., Geelen, V., Fernandez-Cadenas, I., Montaner, J., Schmidt, H., Schmidt, R., Attia, J., Maguire, J., Levi, C., et al. (2010) · Stroke
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 77
- Verified
Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis
Stefanou, M.-I., Theodorou, A., Malhotra, K., Aguiar de Sousa, D., Katan, M., Palaiodimou, L., Katsanos, A. H., Koutroulou, I., Lambadiari, V., Lemmens, R., et al. (2024) · European Stroke Journal
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 60
- Verified
Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study
Michiels, L., Delva, A., van Aalst, J., Ceccarini, J., Vandenberghe, W., Vandenbulcke, M., Koole, M., Lemmens, R., & Laere, K. V. (2021) · NeuroImage
Dementia and Cognitive Impairment ResearchMedical Imaging Techniques and Applications
Cited by 59
- Verified
Spatial decrease of synaptic density in amnestic mild cognitive impairment follows the tau build-up pattern
Vanderlinden, G., Ceccarini, J., Vande Casteele, T., Michiels, L., Lemmens, R., Triau, E., Serdons, K., Tournoy, J., Koole, M., Vandenbulcke, M., et al. (2022) · Molecular Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 47
- Verified
Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
van de Borne, P., Peeters, A., Janssens, L., Leone, A., Lemmens, R., Verhaegen, A., De Meulemeester, M., Balthazar, Y., Heijmans, S., Calozet, Y., et al. (2024) · Acta Cardiologica
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free